New treatments for Alzheimer’s disease are desperately needed, but numerous clinical drug trials have failed to generate promising options. A Harvard based team has developed an AI method to screen currently available medications as possible treatments. The method could represent a rapid and inexpensive way to repurpose existing therapies into new treatments.
The team applied the screening method to 80 FDA-approved and clinically tested drugs for a wide range of conditions. The analysis yielded a ranked list of candidates, with several anti-inflammatory drugs used to treat rheumatoid arthritis and blood cancers emerging as top contenders.